- Home
- FNGR vs NRXP Comparison
FNGR vs NRXP Comparison
Compare FNGR & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FNGR | NRXP |
|---|---|---|
| Founded | 2016 | 2015 |
| Country | Singapore | United States |
| Employees | 65 | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 65.0M | 54.2M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | FNGR | NRXP |
|---|---|---|
| Price | $1.02 | $3.15 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $38.00 |
| AVG Volume (30 Days) | 197.8K | ★ 1.0M |
| Earning Date | 05-28-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $35,607,614.00 | N/A |
| Revenue This Year | N/A | $2,547.84 |
| Revenue Next Year | N/A | $1,591.73 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.81 | $1.65 |
| 52 Week High | $5.20 | $3.84 |
Technical Indicators
Market Signals| Indicator | FNGR | NRXP |
|---|---|---|
| Relative Strength Index (RSI) | 50.03 | 80.57 |
| Support Level | $0.81 | $2.85 |
| Resistance Level | $1.55 | $3.17 |
| Average True Range (ATR) | 0.09 | 0.17 |
| MACD | 0.02 | 0.07 |
| Stochastic Oscillator | 72.46 | 96.76 |
Price Performance
Historical ComparisonAbout FNGR FingerMotion Inc.
FingerMotion Inc is engaged in the provision of mobile payment and recharge services in the Chinese market. The company's business line includes Telecommunications Products and Services, Value Added Products and Services, Short Message Services (SMS) and Multimedia Messaging Services (MMS); a Rich Communication Services (RCS) platform; Data Insights; and a Video Games Division (inactive). It principally earns revenue by providing mobile payment and recharge services to customers of telecommunications companies in China.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.